In a scientific development that bridges the fields of molecular genetics, regenerative medicine, and oncology, researchers at the Perelman School…
Read More
Beyond Chromosome Caps: Penn Medicine Researchers Uncover a Novel Role for TRF2 in Muscle Regeneration and Dystrophy Mitigation
The landscape of molecular biology has long maintained a rigid division of labor for cellular proteins, assigning specific functional zones…
Read More
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
A multi-institutional team of researchers at the University of Toronto has unveiled a next-generation RNA therapeutic platform designed to target…
Read More
Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy
In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…
Read More
Beyond Chromosome Caps: Penn Medicine Researchers Discover Unexpected Role of TRF2 in Muscle Regeneration and Dystrophy
In a significant discovery that reshapes our understanding of cellular biology, researchers at the Perelman School of Medicine at the…
Read More
